(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 4.85% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.36%.
Revvity's revenue in 2025 is $2,769,868,000.On average, 6 Wall Street analysts forecast RVTY's revenue for 2025 to be $336,217,075,928, with the lowest RVTY revenue forecast at $334,739,226,131, and the highest RVTY revenue forecast at $339,087,437,888. On average, 6 Wall Street analysts forecast RVTY's revenue for 2026 to be $357,175,715,912, with the lowest RVTY revenue forecast at $352,607,087,890, and the highest RVTY revenue forecast at $362,524,641,082.
In 2027, RVTY is forecast to generate $383,723,735,173 in revenue, with the lowest revenue forecast at $378,444,117,362 and the highest revenue forecast at $387,287,877,952.